p.stocker@univ-amu.fr Abstract Myeloperoxidase (MPO) is a key enzyme derived from leucocytes which is associated with the initiation and progression of many inflammatory diseases. Increased levels of MPO may contribute to cellular dysfunction and tissues injury by producing highly reactive oxidants such as hypochlorous acid (HOCl). Myeloperoxidase-generated HOCl is therefore considered as a relevant biomarker of oxidative stress-related damage and its quantitation is of great importance to the study of disease progression.
Introduction
Myeloperoxidase (MPO) is a mammalian pro-oxidant enzyme mainly released by activated neutrophils, which catalyzes the conversion of hydrogen peroxide (H2O2) and chloride to hypochlorous acid (HOCl) which in turn readily oxidizes key molecules, such as proteins and lipids. It is well established that MPO promotes endothelium dysfunction leading to various vascular damages and elevated blood MPO and HOCl levels could be predictive for increased risk for cardiovascular events [1] [2] [3] [4] . Among the numerous pathologies associated with increased cardiovascular risk, high-glucose stimulated H2O2 production contributes to MPOmediated atherosclerosis progression in type 2 diabetes mellitus [5] [6] [7] [8] . MPO actions in human health and disease have been widely recognized as specific biomarkers for disease progression, therefore the MPO quantitation in blood and tissues is of great importance in both the experimental and clinical setting.
In clinical practice the most widely used method for MPO detection and quantitation is the enzyme-linked immunosorbent assay (ELISA) method which uses MPO-specific antibodies and which are not relevant for the measurement of the active enzyme. Since then immunological methods have been developed for the measurement of the active content of the enzyme in complex media such as the specific immunological extraction followed by enzymatic detection (SIEFED [9] [10] . The immunological methods have been found to be very sensitive and satisfactorily specific but are expensive and time-intensive. In the research field, few alternative methods have been developed for the detection of chlorination or peroxidase activity of the enzyme using chromogenic and fluorogenic substrates [11] [12] [13] [14] [15] .
However, chlorination and peroxidase activities of the enzyme cannot be measured simultaneously and could be strongly affected by pH, hydrogen peroxide, superoxide, chloride and endogenous inhibitors such as ceruloplasmin, lipoproteins and antioxidants like ascorbic acid [16] [17] [18] [19] .
There are four distinct peroxidase superfamilies that evolved independently in evolution that can oxidize chloride (e.g. chloroperoxidase) [20] . But MPO is the only human peroxidase that produces HOCl at reasonable rates; note that eosinophil peroxidase is able to oxidize chloride only at low pH values [21] . Thus, for the measurement of myeloperoxidase activity, assays based on measurement of chlorination activity are considered more specific than those based on the detection of peroxidase substrates such as 0-dianisidine hydrochloride or tetramethylbenzidine [11, 12] . Therefore, investigating chlorination activity appears more attractive in distinguishing myeloperoxidase from other heme proteins with peroxidase activity. For this purpose, several assays have been developed to measure the chlorination activity of myeloperoxidase and most of them are based on the detection of chloramines which are the HOCl oxidation products of proteins or amino acids [13, 15, 22] . However some weaknesses in the reliability, specificity or sensitivity were reported, rendering these assays hardly applicable to complex biological samples in vivo [14] .
With the aim to overcome some of these later issues, the present study describes a sensitive homogeneous assay allowing the high-throughput MPO quantitation and rapid processing of multiple samples simultaneously in a short period of time. This method was developed to measure the chlorination activity based on MPO-derived HOCl detection which is an endpoint of the actual oxidative capacity of the enzyme. First, a convenient procedure is reported to synthesize 7-hydroxy-2-oxo-2H-chromene-8-carbaldehyde oxime (7-HCCO, Scheme1) as a highly specific fluorescent probe for HOCl detection since the double bond of the oxime could be selectively cleaved by HOCl leading to a strong increase in fluorescence [23] .
Second, the current study reports an accurate method to monitor and quantitate the reaction of HOCl on 7-HCCO, adapted to 96 wells microplate, which is cost-effective and does not require time-consuming steps when compared to ELISA techniques or other methods. The reliability of this method was then investigated by measuring MPO levels in various biologically-relevant milieus such as rat plasma and HL60 cells medium. Finally, the method was successfully applied in vivo (i) to demonstrate MPO-derived HOCl release in streptozotocin (STZ)-treated diabetic rats. (ii) To investigate the relationship between the MPO level and biomarkers of oxidative stress such as protein carbonyls and plasma malondialdehyde or antioxidant defense such as glutathione.
Experimental

Reagents and materials
All chemicals and reagents were obtained from Sigma-Aldrich (Saint-Quentin Fallavier, France) and were of the highest grade available. The protein carbonyl assay kit (Carbofax   ®   ) based on 7-hydrazino-4-nitrobenzo-2,1,3-oxadiazole (NBDH) was purchased from Yelen (Ensuès-la-Redonne, France; http://www.yelen-analytics.com). Analytical NMR spectra were recorded using a Bruker Avance III Nanobay spectrometer. Chemical shifts (δ) are reported in parts per million (ppm) relative to internal Me4Si ( 1 H and 13 C) and coupling constants (J) are given in hertz (Hz). Splitting patterns are reported as follows: s = singlet; d = doublet; dd = doublet of doublets; br = broad peak. The screening assay was performed with a microplate spectrofluorimeter TECAN Infinite 200 (TECAN Männedorf, Switzerland). Doubly distilled deionized water filtered through a 0.2-µm Millipore filter was used throughout. Purified MPO (ref MY176) was supplied by Elastin Products Co (Owensville, USA).
Synthesis of 7-HCCO
The synthesis of probe 7-HCCO was performed according to modifications of a previous procedure [23] . 7-acetylcoumarine (1): 7-hydroxycoumarin (3.09 g, 19.1 mmol) was dissolved in dichloromethane (50 mL). Then acetic anhydride (2 mL, 21.2 mmol) and pyridine (2 drops) were added and the mixture stirred overnight at 38°C. The mixture was then allowed to cool at room temperature and concentrated under vacuum. The residue was dissolved in water (50 mL) and ethyl acetate (100 mL). The aqueous layer was extracted with ethyl acetate (3 × 50 mL). The organic layers were gathered, washed with an aqueous saturated solution of K2CO3 (3 × 50 mL), dried over MgSO4, filtered and concentrated to afford 1 as a white powder (3.9 g, quant.). 8-formyl-7-hydroxycoumarine (2): Compound 1 (3.9 g, 19.1 mmol) was dissolved in trifluoroacetic acid (26 mL) and the solution was cooled at 0°C. Hexamethylenetetramine (3.8 g, 27.5 mmol) was then added; the resulting solution was allowed to warm at room temperature and then heated under reflux overnight. The mixture was then concentrated under vacuum and the residue was suspended in water (52 mL) and heated at 60°C for 30 min. The mixture was then cooled at 0°C to afford 2 as an orange powder that was filtered and dried 
7-hydroxy-2-oxo-2H-chromene-8-carbaldehyde oxime (7-HCCO):
Hydroxylamine hydrochloride (750 mg, 10.7 mmol) and triethylamine (1.5 mL, 10.7 mmol) were added to a solution of compound 2 (1.35 g, 7.11 mmol) in absolute ethanol (20 mL 
HOCl production by isolated myeloperoxidase
Myeloperoxidase was mixed at 37°C in 1X PBS pH 6.5 with 7-HCCO probe at 150 µM in 96 wells microplate and H2O2 (100 µM) was added to start the reaction. The fluorescence was measured every 3 min at 470 nm, exciting at 350 nm. Fluorescence intensity change (∆F) was directly proportional to the quantity of active MPO and related to a standard curve to determine the concentration of hypochlorous acid produced. One unit (U) of the enzyme was the activity which formed 1 µmol HOCl per min at 37°C calculated from the initial rate of reaction with peroxide as the substrate.
HOCl production by HL-60 cells
The characteristics and origin of HL60 cell line used in the present study was purchased from ATCC (Rockville, MD). HL60 (acute promyelocytic leukemia) is a promyelocytic cell line derived by S.J. Collins et al. [24] . Peripheral blood leukocytes were obtained by leukopheresis from a 36-year-old Caucasian female with acute promyelocytic leukemia. Cells
alanyl-L-glutamine and supplemented with 100 U/mL penicillin and 100 µg/mL streptomycin at 37°C in 5% carbon dioxide atmosphere. Cells (5 × 10 6 /mL) were lysed by a freeze/thaw treatment and sonicated on ice for 10 min. Cell lysates were centrifuged for 10 min at 15,000 × g at 4°C. Two hundred µL of supernatant 10 times diluted in 1X PBS pH 6.5 was preincubated 30 min at 37°C with 20 µL PBS 1X or 20 µL of sodium azide (10 mM) in 96 wells microplate. After 10 min of incubation at 37°C, 7-HCCO at 100 µM and H2O2 at 100 µM were added and fluorescence was measured every 3 min at 470 nm, exciting at 350 nm. To induce diabetes, streptozotocin (STZ) was administered to twelve overnight fasted rats (STZ-diabetic group) by a single intraperitoneal injection (final dose 60-70 mg/kg in 0.4-0.5 mL). STZ was dissolved beforehand in citrate buffer (1 mM, pH 4.5) and maintained on ice before use. Seventy-two hours after STZ injection, the blood glucose concentration was checked using a commercial glucose auto analyser (AlphaTRAK®, Abbott Laboratories).
Animals and biological samples preparation
Blood samples (6 μL/sample) were collected from the tail vein under local anaesthesia induced by 0.25% lidocaine application in ointment (B Braun, France). In the study, a blood glucose level higher than 350 mg.dL -1 was found in 100% of animals which were considered to be diabetic and used in the experiments. During the 3 weeks following STZ injection blood samples were collected weekly and the blood glucose level was measured in fasting (5-6 h, morning fast) conditions. A second group of twelve untreated rats was used for control (non diabetic control group). All animals were observed daily for clinical signs of suffering, weight loss and moribundity. At the end of the protocol, animals were euthanized by intraperitoneal injection of sodium pentobarbital (120 mg.kg -1 ; Ceva Santé Animale, Libourne, France) before thoratocomy. The blood was withdrawn from the heart cavity and immediately added to serine borate buffer and processed for GSH and GSSG determination (see below) or into heparinized glass tubes for plasma preparation by centrifugation (1,650 × g for 15 min at 3°C) and kept at -80°C for further analysis of MPO, protein carbonyls and MDA-TBA levels.
Chlorination activity of myeloperoxidase in rat plasma
Plasma samples from control normal rats were diluted ten-fold in 1X PBS pH 6.5. One hundred µL of diluted plasma was placed in 96 wells microplate. Then 7-HCCO at 100 µM and H2O2 at 100 µM were added and fluorescence was measured every 3 minutes at 470 nm, exciting at 350 nm during 15 minutes. MPO content was calculated from the relative linear fluorescence intensity and related to a calibration curve constructed in plasma with purified human MPO. The precision of the method was estimated by the coefficients of variation (CV) calculated for several determinations made in triplicate.
GSH and GSSG quantitation
GSH and GSSG were determined in the blood of diabetic and control rats according to the method previously described by N'Guessan et al. [25] 
Statistical analysis
Data are presented as mean ± SD or SEM for the indicated number of independent experiments performed in duplicate. Evaluation of statistical significance was conducted using an unpaired Student's t test or Mann-Whitney when appropriate (GraphPad Prism Software). Differences were considered significant when P < 0.05.
Results
Synthesis and characterization of probe 7-HCCO
Synthesis of probes 7-HCCO and oxidized 7-HCCO is reported in Scheme 1. Acetylation of 7-hydroxycoumarine, which afforded compound 1 in a quantitative yield. The formulation of compound 1 was performed through a Duff reaction inspired from the synthesis described by Lee et al. [27] to give compound 2 in a moderate yield. Reaction of aldehyde with hydroxylamine gave the probe 7-HCCO with a 26 % overall yield. To verify the dehydration of the probe into the nitrile, reaction of 7-HCCO with sodium hypochlorite was performed.
The dehydration was proved by the disappearance of the signal attributed to the oxime function (δ 8.53 ppm in 7-HCCO) a result which positively correlates to the previously reported spectra [23] . . Under these conditions, the limit of detection for HOCL is estimated to be 8 µM.
Chlorination activity of purified MPO
It is known that the optimum pH of the MPO-catalyzed chlorination reaction varies with chloride and H2O2 concentrations. Under usual experimental conditions the activity of the MPO-H2O2-halide system has an optimum pH varying from 4 to 7.4 depending on the Under the conditions of the assay, concentrations as low as 5 µg/L myeloperoxidase could be reliably detected.
MPO chlorination activity in HL-60 cells
To study whether the 7-HCCO probe can detect HOCl generated by MPO in biological samples, HL-60 cells were first used for the experiments. Fig. 4 shows the kinetic curves for 7-HCCO oxidation in HL-60 cell lysate. A fluorescence increase is clearly recorded without the heme enzyme inhibitor sodium azide. The inhibition of MPO activity by azide was greater than that observed in the absence of H2O2, suggesting that azide action goes beyond simple inhibition of MPO activity.
MPO activity in rat plasma
Having established that the probe 7-HCCO can detect MPO activity in isolated cells, the probe was then used to provide direct evidence of HOCl formed by MPO in rat plasma.
Samples were diluted 10 fold in order to reduce the effects of native MPO inhibitors such as ceruloplasmin or ascorbic acid [30] . At a higher dilution, the limit of the sensitivity is reached by samples with a low content of active MPO. The precision of the method was estimated by repeatedly measuring the same assay with five different concentrations of active MPO. These MPO concentrations were added to the same sample and ranged from 8 to 125 µg/L. Using the current assay, a calibration curve was built (15 µM of 7-HCCO and 100 µM H2O2) with twenty different rat plasma samples that were supplemented with incremental purified human MPO concentrations (standard curve ∆F = 0.7633c, R 2 =0.9981). Intra-assay CV ranged from 4% to 9.8% and the inter-assay CV ranged from 6.9% to 13.9%. The MPO concentrations were chosen to reach common ranges found in other studies or commercial kits [29] [30] [31] . In each sample MPO content was calculated from the calibration curve.
Comparative measurements of MPO to multiple oxidative stress status biomarkers in diabetic rats
With the aim to test the ability of the method in a relevant physiopathological model known to trigger oxidative stress and inflammation, MPO levels were measured in plasma samples from rats allocated to control or STZ-diabetic groups (n=12/group). It was checked beforehand that all rats of the STZ-diabetic group have developed hyperglycemia within 3-5 days after STZ injection, as indicated by increased blood glucose concentrations (231 ± 8 mg.dL -1 in STZ-treated rats versus 79 ± 2 mg.dL -1 in controls, P<.0.01). The content of protein carbonyls, glutathione and oxidized glutathione and the malondialdehyde levels was determined for each animal 3 weeks after STZ injection, and the results are reported in Fig. 5 .
It was shown that the values of MPO level (± SEM) in diabetic rat plasma samples (433 ± 19 µg/L) were significantly higher (P<0.001) than the values obtained in control animals (106 ± 6 µg/L). The values of GSH blood content in the STZ group (87 ± 11 µmol.L -1 ) were found to be significantly lower than that of the controls (264 ± 19 µmol.L -1 ). In addition, a significant increase (by 65%) in the GSSG content was observed in the blood of diabetic rats when compared to controls (26 ± 5 µmol.L -1 ). As expected, these changes were accompanied by a significant 80% decrease of the ratio GSH/GSSG in the STZ group when compared to normal rats (Fig.5 ). This drop in GSH/GSSG was found concomitant with a dramatically increased blood glucose level (498 ± 15 mg.dL -1 ) when compared to controls. As described in GSH/GSSG and MPO could be drawn (Fig. 6B) , which supports the hypothesis that the MPO-derived HOCl may contribute to oxidative stress in the STZ-induced model of experimental diabetes. In addition, Figure 5 shows that the lipid peroxidation degree (MDA-TBA levels) in the plasma of the diabetic group (7.61 ± 0.34 nmol/mg protein) was significantly higher than that of the controls (4.26 ± 0.31 nmol/mg protein; P<0.001).
Discussion
The MPO level could be a representative marker of neutrophil activation [32] and it is well established that myeloperoxidase-derived HOCl plays a crucial role in several pathologies and diseases. Therefore, the determination of the enzyme concentration is essential for the understanding of its role as one of the major components of the inflammatory process. The ELISA assay is considered to be robust and sensitive, but it is time intensive, costly and allows the evaluation of the total content of the enzyme and not the active one. Despite other methods based on the quantitation of MPO enzymatic activity that have been proposed, no consensus has been found regarding their ability to specifically measure MPO activity in biological samples. Most of them are based on the properties of chemical probes such as odianisidine, guaiacol, luminol, tetramethylbenzidine (TMB) or acetyl-dihydroxyphenoxazine (ADPH) for measuring the peroxidase activity. The ADPH and luminol assays were found to be sensitive enough but not specific to MPO activity since the activity of other peroxidases, including eosinophil and hemoproteins such as hemoglobin and myoglobin present in the tissues, can interfere with the results. In contrast the probes 3'-(p-aminophenyl) fluorescein (APF) and 5-thio-2-nitrobenzoic acid (TNB) have the ability to detect the chlorination activity of MPO but were found to lack sensitivity or required long incubation steps. Another assay of MPO activity has been developed based on the detection of 3-chlorotyrosine, the HOCl oxidation product of protein tyrosyl residues, that can be measured with chromatography/mass spectrometry [33, 34] . Although 3-chlorotyrosine is specifically produced under MPO stimulation, it can be quickly degraded in an inflammatory environment or markedly reduced by thiocyanate ions [35] . The bromide-dependent chemiluminescence has also been shown to be specific towards MPO but this technique can only be used for the quantification of polymorphonuclear leukocytes in selected tissues with an appropriate control [36, 37] . All together, these assays are dependent on the tissue microenvironment and cannot be specific towards MPO without the use of an antibody-capture step. Some authors found a good compromise to measure in complex media the activity of MPO after its capture by specific antibodies by using for example the SIEFED technique [9, 10] .
In the present study, a homogeneous assay that uses a new fluorimetric method in order to measure MPO in plasma and other biological samples was proposed as an alternative to ELISA and other assays. This method allows the direct determination of chlorination activity of myeloperoxidase based on a synthetic probe designed to selectively detect HOCl, and has been used to measure active MPO level for the first time in STZ-diabetic rats. This assay has many practical advantages over other methods. The most obvious is that it saves time as it requires only 10 minutes of incubation in order to observe a linear increase in fluorescence intensity. Also, it is homogeneous and requires no labor-intensive sample preparation; biological samples were only diluted in order to reduce the interactions between MPO and other biomolecules. Since it uses a fluorogenic and selective probe for HOCl detection, the technique disclose the MPO activity and allows an easy measurement of the active MPO level with a high specificity and sensitivity. It is adapted to 96 wells microplate allowing highthroughput quantitation of MPO in multiple samples concurrently.
One limitation of our assay is the lower sensitivity compared to ELISA or SIEFED techniques [6, 10] . The assay's detection limit is based on a 3-sigma criterion that corresponds to approximately 8 µg/L, which is about 10 fold higher than immunological methods. However, as the mean MPO concentrations in human plasma of healthy donors were reported to range 18 to 49 µg/L for total level [10, 30, 38, 39] , or 14 -15 µg/l for active level [10, 30] , the sensitivity of the probe should be therefore sufficient to measure MPO level in vivo, even when in a low grade of oxidative stress and could serve for investigation of inflammatory pathologies.
In rats, STZ treatment lead to an activation and degranulation of polymorphonuclear neutrophils as revealed by the percentage increase (380 %) of MPO level in plasma of diabetic group when compared to the control. Our results are in accordance with a previous murine study that shows an increase of 192 % of plasma MPO concentration in diabetic animals [40] . A significant increase was also observed (178 % to 342 %) in some tissues of STZ-induced diabetic rats [41] [42] [43] [44] [45] . Taken together all these results confirm the assumption of increased inflammation in diabetic animals in this model.
Myeloperoxidase-derived HOCl can react readily with a number of biological molecules. In a complex system such as plasma, proteins are important targets for HOCl, leading to an increase of protein-bound carbonyl levels [46] . Many studies have demonstrated a significant increase of protein carbonyl content in plasma and different cells of diabetic patients resulting from increased myeloperoxidase activity [47] [48] [49] . A correlation between protein carbonyl levels and MPO concentrations has been reported previously in preterm infants [50] . Released
HOCl is able to penetrate the cell membrane and oxidize intracellular thiols. Glutahione oxidation in erythrocyte by HOCl is considered to be a highly selective process and most of the GSH is converted into GSSG [51] . Glutathione is the most abundant cellular non-protein thiol which plays an efficient role against oxidative stress. It is present in almost all mammalian tissues, at millimolar concentrations in liver, and less than 10% exists in the oxidized form in a normal situation. The ratio GSH/GSSG is considered as a major biomarker of blood redox state or overall health [52] . As a consequence of an increased oxidative status, alterations of GSH and GSSG concentrations are rapidly observed. A decreased GSH level plays a role in the oxidative damage and many works have shown that the GSH/GSSG ratio was much lower in the diabetic subjects than in controls [53] [54] [55] . The reduction in GSH concentration observed after STZ treatment is due to its increased utilization and reduced regeneration, and is presumably associated with an increased production of peroxides [56] . In accordance with these findings, we observed in the present study that after 3 weeks of STZinduced hyperglycemia a strong correlation could be established between MPO concentrations and both protein carbonyls and GSH/GSSG ratio, suggesting that neutrophil activation is one of the major contributors to the variations of these markers. 
Conclusions
In summary, it can be concluded that 7-HCCO could be used as a convenient and sensitive 
